{"id":"https://openalex.org/W2011185278","doi":"https://doi.org/10.3727/096504012x13473664562466","title":"Antitumor Properties of Taxol in Combination With Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Tumor Growth In Vivo","display_name":"Antitumor Properties of Taxol in Combination With Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Tumor Growth In Vivo","publication_year":2012,"publication_date":"2012-10-30","ids":{"openalex":"https://openalex.org/W2011185278","doi":"https://doi.org/10.3727/096504012x13473664562466","mag":"2011185278","pmid":"https://pubmed.ncbi.nlm.nih.gov/23193911"},"language":"en","primary_location":{"id":"doi:10.3727/096504012x13473664562466","doi":"https://doi.org/10.3727/096504012x13473664562466","is_oa":true,"landing_page_url":"https://doi.org/10.3727/096504012x13473664562466","pdf_url":null,"source":{"id":"https://openalex.org/S146643948","display_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","issn_l":"0965-0407","issn":["0965-0407","1555-3906"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4360969325","host_organization_name":"Cognizant Communication Corporation","host_organization_lineage":["https://openalex.org/P4360969325"],"host_organization_lineage_names":["Cognizant Communication Corporation"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.3727/096504012x13473664562466","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100317967","display_name":"Wei Li","orcid":"https://orcid.org/0000-0001-5696-4309","observed_orcids":["https://orcid.org/0000-0001-5696-4309"]},"institutions":[{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":["Department of Gynecology, Nanjing Medical University of Hangzhou Hospital, Hangzhou, Zhejiang, China. wei5901482@tom.com","Department of Gynecology, Nanjing Medical University of Hangzhou Hospital, Hangzhou, Zhejiang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecology, Nanjing Medical University of Hangzhou Hospital, Hangzhou, Zhejiang, China. wei5901482@tom.com","institution_ids":["https://openalex.org/I83519826"]},{"raw_affiliation_string":"Department of Gynecology, Nanjing Medical University of Hangzhou Hospital, Hangzhou, Zhejiang, China","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108817358","display_name":"Lingyun Zhai","orcid":"https://orcid.org/0009-0004-4092-4053","observed_orcids":["https://orcid.org/0009-0004-4092-4053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lingyun Zhai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008196856","display_name":"Yun-Xian Tang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yunxian Tang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025741281","display_name":"Jiahui Cai","orcid":"https://orcid.org/0000-0002-6962-5696","observed_orcids":["https://orcid.org/0000-0002-6962-5696"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiahui Cai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Meilin Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meilin Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Jun Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7759,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.81529972,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"20","issue":"2","first_page":"49","last_page":"59"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.711899995803833,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.711899995803833,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.21400000154972076,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.023800000548362732,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9779999852180481},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.8389999866485596},{"id":"https://openalex.org/keywords/cyclooxygenase-1-inhibitors","display_name":"cyclooxygenase-1 inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.996999979019165},{"id":"https://openalex.org/keywords/sc-560","display_name":"SC-560","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/skov-3-cells","display_name":"SKOV3 cells","score":0.9549999833106995},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.925000011920929},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.9750000238418579},{"id":"https://openalex.org/keywords/cyclin-d1","display_name":"cyclin D1","score":0.8989999890327454},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.843999981880188},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.9153881072998047},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.6650745868682861},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6343298554420471},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6294116377830505},{"id":"https://openalex.org/C196795494","wikidata":"https://www.wikidata.org/wiki/Q1624817","display_name":"TUNEL assay","level":3,"score":0.6179132461547852},{"id":"https://openalex.org/C199835354","wikidata":"https://www.wikidata.org/wiki/Q15311861","display_name":"Cyclin D1","level":4,"score":0.5261549353599548},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5192287564277649},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4951428472995758},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.49145328998565674},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4906982183456421},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.4749244153499603},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.4641737937927246},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4430426359176636},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.3404543697834015},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3280280828475952},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2763561010360718},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26024991273880005},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1404135525226593},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08791330456733704},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007124","descriptor_name":"Immunoenzyme Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020287","descriptor_name":"In Situ Nick-End Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051545","descriptor_name":"Cyclooxygenase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3727/096504012x13473664562466","doi":"https://doi.org/10.3727/096504012x13473664562466","is_oa":true,"landing_page_url":"https://doi.org/10.3727/096504012x13473664562466","pdf_url":null,"source":{"id":"https://openalex.org/S146643948","display_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","issn_l":"0965-0407","issn":["0965-0407","1555-3906"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4360969325","host_organization_name":"Cognizant Communication Corporation","host_organization_lineage":["https://openalex.org/P4360969325"],"host_organization_lineage_names":["Cognizant Communication Corporation"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:23193911","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23193911","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3727/096504012x13473664562466","doi":"https://doi.org/10.3727/096504012x13473664562466","is_oa":true,"landing_page_url":"https://doi.org/10.3727/096504012x13473664562466","pdf_url":null,"source":{"id":"https://openalex.org/S146643948","display_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","issn_l":"0965-0407","issn":["0965-0407","1555-3906"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4360969325","host_organization_name":"Cognizant Communication Corporation","host_organization_lineage":["https://openalex.org/P4360969325"],"host_organization_lineage_names":["Cognizant Communication Corporation"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1966343985","https://openalex.org/W2057244085","https://openalex.org/W1990026287","https://openalex.org/W1999026714","https://openalex.org/W3093134632","https://openalex.org/W2397890071","https://openalex.org/W1616622661","https://openalex.org/W45870531","https://openalex.org/W1998119264","https://openalex.org/W1973249538"],"abstract_inverted_index":{"The":[0,41],"present":[1],"study":[2],"was":[3,141,202],"designed":[4],"to":[5,236],"investigate":[6],"whether":[7],"taxol":[8,26,72,229,237],"in":[9,56,81,111,137,245,254],"combination":[10,57,82,96,252],"with":[11,34,45,58,83,181],"cyclooxygenase":[12],"(COX)":[13],"inhibitors":[14,232],"could":[15],"be":[16,234,257],"superior":[17,235],"on":[18,200],"inhibitory":[19],"effect":[20],"of":[21,31,94,100,104,121,159,166,183,228,250,264],"ovarian":[22,36,243],"cancer":[23,244],"growth":[24],"than":[25,145],"alone":[27,54,73,238],"as":[28,239],"drug":[29,240],"therapy":[30,241],"mice":[32],"implanted":[33],"human":[35],"carcinoma":[37],"cell":[38,101,160,265],"line":[39],"SKOV-3.":[40],"animals":[42],"were":[43,114,170],"treated":[44],"100":[46],"mg/":[47],"kg":[48],"celecoxib":[49],"(a":[50,62],"COX-2":[51],"selective":[52,64],"inhibitor)":[53,65],"or":[55,80,85],"3":[59,88],"mg/kg":[60],"SC-560":[61],"COX-1":[63],"by":[66,74,116,124],"gavage":[67],"twice":[68],"a":[69,78],"day,":[70],"20mg/kg":[71],"intraperitoneal":[75],"(IP)":[76],"once":[77],"week":[79],"celecoxib,":[84],"SC-560/celecoxib/taxol":[86,139,155,206],"for":[87],"weeks.":[89],"To":[90],"test":[91],"the":[92,95,98,119,125,138,154,157,184,205,211,224,251],"mechanism":[93],"treatment,":[97],"index":[99,120,158],"proliferation,":[102],"expression":[103],"cyclin":[105,167],"D1,":[106],"and":[107,118,162,164,173,192,210,230,247,262,267],"microvessel":[108],"density":[109],"(MVD)":[110],"tumor":[112,135],"tissues":[113],"determined":[115],"immunohistochemistry":[117],"apoptotic":[122],"cells":[123,169],"terminal-deoxynucleotidyl-transferase-mediated":[126],"deoxyuridine":[127],"triphosphate":[128],"nick":[129],"end":[130],"labeling":[131],"(TUNEL)":[132],"method.":[133],"Mean":[134],"volume":[136],"group":[140,186,216],"first":[142],"significantly":[143],"lower":[144],"control":[146,185,212],"at":[147],"day":[148],"14":[149],"(p":[150,217],"<":[151,189,196,218],"0.05).":[152,197],"In":[153],"group,":[156],"proliferation":[161,266],"apoptosis":[163,261],"quantification":[165],"D1-postive":[168],"6.93%,":[171],"69.62%,":[172],"19.14%,":[174],"respectively,":[175],"which":[176],"are":[177],"statistically":[178],"significant":[179],"compared":[180],"those":[182],"(29.85%,":[187],"p":[188,195],"0.001;":[190],"32.81%":[191],"36.99%,":[193],"both":[194],"Statistical":[198],"significance":[199],"MVD":[201],"observed":[203],"between":[204],"(39.57":[207],"+/-":[208,214],"4.98)":[209],"(73.2":[213],"1.96)":[215],"0.001).":[219],"Our":[220],"results":[221],"suggest":[222],"that":[223,248],"combined":[225],"antitumor":[226],"efficacy":[227],"COX":[231],"may":[233,256],"against":[242],"mice,":[246],"synergism":[249],"treatment":[253],"part":[255],"mediated":[258],"through":[259],"accelerated":[260],"suppression":[263],"angiogenesis.":[268]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}